Senolytic therapy for diabetic macular edema (DME) refractory to anti-VEGF treatment appears safe, and preliminary data suggest a therapeutic effect on visual acuity and macular thickness.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Teo, Z. L. et al. Ophthalmology 128, 1580–1591 (2021).
Ciulla, T. A., Pollack, J. S. & Williams, D. F. Br. J. Ophthalmol. 105, 216–221 (2021).
Wykoff, C. C. et al. Lancet 399, 741–755 (2022).
Crespo-Garcia, S. et al. Nat. Med. https://doi.org/10.1038/s41591-024-02802-4 (2024).
Antonetti, D. A., Silva, P. S. & Stitt, A. W. Nat. Rev. Endocrinol. 17, 195–206 (2021).
Oshitari, T. Int. J. Mol. Sci. 24, 12919 (2023).
Gorgoulis, V. et al. Cell 179, 813–827 (2019).
Liu, H. et al. JCI Insight 8, e168945 (2023).
El-Nimri, N. W. et al. Sci. Rep. 10, 21752 (2020).
Wong, F., Omori, S., Donghia, N. M., Zheng, E. J. & Collins, J. J. Nat. Aging 3, 734–750 (2023).
Cordeiro, M. F. et al. Prog. Retin. Eye Res. 86, 100976 (2022).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Murakami, T., Gardner, T.W. Rejuvenation of diabetic macular edema with senolytic therapy. Nat Med 30, 346–347 (2024). https://doi.org/10.1038/s41591-024-02804-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-024-02804-2